ATE510018T1 - Synthetische menschliche gene und polypeptide und deren verwendung in der behandlung von autoimmunkrankheiten - Google Patents

Synthetische menschliche gene und polypeptide und deren verwendung in der behandlung von autoimmunkrankheiten

Info

Publication number
ATE510018T1
ATE510018T1 AT00971684T AT00971684T ATE510018T1 AT E510018 T1 ATE510018 T1 AT E510018T1 AT 00971684 T AT00971684 T AT 00971684T AT 00971684 T AT00971684 T AT 00971684T AT E510018 T1 ATE510018 T1 AT E510018T1
Authority
AT
Austria
Prior art keywords
treatment
autoimmune diseases
synthetic human
autoantigen
polypeptides
Prior art date
Application number
AT00971684T
Other languages
English (en)
Inventor
Avraham Ben-Nun
De Rosbo Nicole Kerlero
Gregor Sappler
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE510018T1 publication Critical patent/ATE510018T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Rehabilitation Therapy (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00971684T 1999-10-27 2000-10-26 Synthetische menschliche gene und polypeptide und deren verwendung in der behandlung von autoimmunkrankheiten ATE510018T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13261199A IL132611A0 (en) 1999-10-27 1999-10-27 Synthetic genes and polypeptides and pharmaceutical compositions comprising them
PCT/IL2000/000688 WO2001031037A2 (en) 1999-10-27 2000-10-26 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
ATE510018T1 true ATE510018T1 (de) 2011-06-15

Family

ID=11073389

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00971684T ATE510018T1 (de) 1999-10-27 2000-10-26 Synthetische menschliche gene und polypeptide und deren verwendung in der behandlung von autoimmunkrankheiten

Country Status (7)

Country Link
US (2) US8088389B1 (de)
EP (1) EP1238089B1 (de)
AT (1) ATE510018T1 (de)
AU (1) AU1051001A (de)
CA (1) CA2404438A1 (de)
IL (2) IL132611A0 (de)
WO (1) WO2001031037A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1573022E (pt) 2001-04-10 2011-08-23 Agensys Inc Ácido nucleico e proteína correspondente intitulada 184p1e2, utilizadas para o tratamento e detecção de cancro
IL146016A0 (en) * 2001-10-17 2002-07-25 Yeda Res & Dev Synthetic peptides and dna sequences and compositions comprising them for treatment of multiple sclerosis
CA2527830A1 (en) * 2003-06-02 2004-12-23 Mercia Pharma, Inc. Therapeutic vaccine compositions for the treatment of type 1 diabetes
EP1835933A4 (de) * 2005-01-04 2015-01-07 Yeda Res & Dev Hsp60, hsp60-peptide und t-zellen-impfstoffe zur immunmodulation
US12370251B2 (en) 2009-11-05 2025-07-29 Mercia Pharma, Inc. Adjuvanted nanoparticulate influenza vaccine
PL217128B1 (pl) * 2010-08-02 2014-06-30 Inst Biochemii I Biofizyki Polskiej Akademii Nauk Syntetyczne geny kodujące fragmenty peptydowe naturalnych białek mielinowych przeznaczone do wywoływania efektu tolerancji pokarmowej, fragmenty DNA zawierające te geny, sposób otrzymywania tych peptydów w układzie mikrobiologicznym (bakteryjnym) oraz ich zastosowanie medyczne
US9040046B2 (en) 2011-01-31 2015-05-26 Kai Xu Sodium pump antibody agonists and methods of treating heart disease using the same
WO2013104424A1 (en) * 2012-01-13 2013-07-18 Instytut Biochemii I Biofizyki Pan Synthetic genes encoding peptide fragments of natural myelin proteins for induction of oral tolerance, dna fragment comprising these genes, means of obtaining these peptides in a microbial (bacterial) system and their medical application
WO2013107526A2 (en) * 2012-01-22 2013-07-25 Instytut Biochemii I Biofizyki Pan Synthetic genes encoding peptide fragments of natural myelin proteins for induction of oral tolerance, dna fragment comprising these genes, means of obtaining these peptides in a microbial (bacterial) system and their medical application
GB201300684D0 (en) 2013-01-15 2013-02-27 Apitope Int Nv Peptide
AU2015349728A1 (en) 2014-11-21 2017-07-13 Immusant, Inc. Peptides for use in treatment and diagnosis of type 1 diabetes
US10759838B2 (en) * 2015-03-09 2020-09-01 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of use
US12458683B2 (en) 2015-03-09 2025-11-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of use
CN113336862B (zh) * 2021-07-05 2022-03-01 广东省科学院动物研究所 一种抗多发性硬化的重组蛋白及其制备方法和用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547669A (en) * 1989-11-03 1996-08-20 Immulogic Pharma Corp Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I
IL103456A (en) 1991-10-16 2006-06-11 Merck Patent Gmbh Isolated peptides having t-cell stimulating activity
US5683695A (en) * 1993-02-10 1997-11-04 United Biomedical, Inc. Production of recombinant proteins containing multiple antigenic determinants linked by flexible hinge domains
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
WO1995025744A1 (en) 1994-03-21 1995-09-28 Rijksuniversiteit Utrecht Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases
JPH11511650A (ja) * 1995-05-02 1999-10-12 アレクション・ファーマシューティカルズ・インク 改変されたミエリンタンパク質分子
IL118524A (en) 1995-06-19 2004-02-19 Akzo Nobel Nv Peptides and pharmaceutical preparations containing them useful in the treatment of peptide tolerance
US5821334A (en) * 1996-01-26 1998-10-13 Vanderbilt University Insulin-dependent diabetes mellitus-specific chimeric polypeptides
IL120561A0 (en) 1996-04-24 1997-07-13 Akzo Nobel Nv Peptides suitable for use in immunosuppressive therapy
US6274136B1 (en) * 1996-05-29 2001-08-14 University Of Southern California Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
AUPO468597A0 (en) * 1997-01-21 1997-02-13 Montech Medical Developments Pty Ltd Expression in yeast of antigenically active, recombinant hybrid glutamic acid decarboxylase
WO1999032136A1 (en) * 1997-12-23 1999-07-01 Alexion Pharmaceuticals, Inc. Chimeric proteins for the treatment of diabetes
US6770460B1 (en) * 1998-01-29 2004-08-03 Wallac Oy Fusion protein and its use in an immunoassay for the simultaneous detection of autoantibodies related to insulin-dependent diabetes mellitus
US7030098B2 (en) 1999-03-12 2006-04-18 The Board Of Trustees Of The Leland Stanford Junior University DNA vaccination for treatment of autoimmune disease
IL146016A0 (en) 2001-10-17 2002-07-25 Yeda Res & Dev Synthetic peptides and dna sequences and compositions comprising them for treatment of multiple sclerosis

Also Published As

Publication number Publication date
CA2404438A1 (en) 2001-05-03
AU1051001A (en) 2001-05-08
IL149325A (en) 2009-12-24
US20120172297A1 (en) 2012-07-05
US8088389B1 (en) 2012-01-03
EP1238089A2 (de) 2002-09-11
WO2001031037A2 (en) 2001-05-03
US8501189B2 (en) 2013-08-06
WO2001031037A3 (en) 2002-07-11
EP1238089B1 (de) 2011-05-18
IL132611A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
ATE510018T1 (de) Synthetische menschliche gene und polypeptide und deren verwendung in der behandlung von autoimmunkrankheiten
RU2353625C2 (ru) Миметики человеческого глюканоподобного пептида-1 и их применение в лечении диабета и родственных состояний
ATE319827T1 (de) Polypeptid, das die differenzierung unterdrueckt
UA100222C2 (uk) Тканинозахисні пептиди і їх застосування
BG109433A (en) RET (RetL) Lead for Stimulating Nerve and Rat Growth
EP1350848A3 (de) T-Zell-Membranprotein (TIRC7), dafür kodierendes Gen und Antikörper dagegen und ihre Verwendungen
NZ332829A (en) Use of a polypeptide corresponding to a serine threonine kinase receptor, ALK-7 for neurological diseases
IL111196A0 (en) Peptides and pharmaceutical compositions comprising them
Mantzourani et al. Structural requirements for binding of myelin basic protein (MBP) peptides to MHC II: effects on immune regulation
WO1998031795A3 (en) Novel human metallothionein
EP1520859B9 (de) Hydrophile Signal-Oligopeptide und Verfahren der therapeutischen Anwendung
WO2001044291A3 (en) Polynucleotid encoding the rg1 polypeptide
WO2002050111A3 (en) Isolated laminin 10
ATE264112T1 (de) Verwendung von il-7 zur behandlung von autoimmunkrankheiten, insbesondere insulinabhängigem diabetes mellitus
BRPI0409948A (pt) composições de spex e processos de uso
ES2145979T3 (es) Procedimiento de redistribucion de policarbonatos.
WO1999030670A3 (en) Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
RU2001105086A (ru) Новые пептиды для применения в иммунотерапии аутоиммунных заболеваний
WO2001098355A3 (en) Cgi-69 compositions and methods of use
WO2006009890A3 (en) Methods and compositions for producing insulin sensitization
SE9402332D0 (sv) Igf-1
AU5276296A (en) Medicament containing at least one part of the ul84 protein of the cytomegalovirus, use of polypeptides corresponding to the amino acid sequence of the ul84 protein, and process for introducing ul84 into target cells
Strohecker et al. Total ankle arthroplasty-a therapeutic alternative after posttraumatic arthritis?
Krauthammer Time for a little panic.
Konishi et al. Four Cases of Giant Cell Tumor of Tendon Sheath arising from the Finger

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties